Posted by SLS on March 3, 2002, at 19:33:15
In reply to Re: Duloxetine » Bob, posted by SLS on March 3, 2002, at 12:54:07
Here's a new one (sort of):
http://pharmalicensing.com/news/adisp/982274821_3a8c5305199e4
Excerpts:
"GlaxoSmithKline plc and Merck KGaA have signed a worldwide
development and commercialisation agreement for an antidepressant
with a novel mechanism of action.""The compound, currently known as EMD 68843 or SB 659746-A, is in
Phase II clinical development.""It combines the properties of a selective serotonin- reuptake
inhibitor with those of a 5-HT1A partial agonist."
Does anyone know how long it takes for a drug in phase-II trials to be approved?- Scott
poster:SLS
thread:95939
URL: http://www.dr-bob.org/babble/20020301/msgs/96227.html